Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Cancer
|
October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study
John C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cancer Research
|
May 3, 2008
Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model
Serk In Park, Jing Zhang, Kacy A Phillips, et al.
Cancer Research
|
May 3, 2003
Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice
Niels Reinmuth, Wenbiao Liu, Syed A Ahmad, et al.
Cancer Research
|
March 15, 2018
Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II
Guoyu Yu, Chien-Jui Cheng, Song-Chang Lin, et al.
Annals of Surgical Oncology
|
June 25, 2011
Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy
Michael P Kim, Mark J Truty, Woonyoung Choi, et al.
The American Journal of Pathology
|
March 2, 2006
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
Jose G Trevino, Justin M Summy, Donald P Lesslie, et al.
Plos One
|
March 4, 2014
Cadherin-11 in renal cell carcinoma bone metastasis
Robert L Satcher, Tianhong Pan, Chien-Jui Cheng, et al.
Cancer Research
|
April 23, 2009
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress
Scott Kopetz, Donald P Lesslie, Nikolas A Dallas, et al.
Cancer Research
|
July 4, 2003
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways
Wenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes
Justin M Summy, Jose G Trevino, Donald P Lesslie, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Cancer
|
October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study
John C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cancer Research
|
May 3, 2008
Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model
Serk In Park, Jing Zhang, Kacy A Phillips, et al.
Cancer Research
|
May 3, 2003
Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice
Niels Reinmuth, Wenbiao Liu, Syed A Ahmad, et al.
Cancer Research
|
March 15, 2018
Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II
Guoyu Yu, Chien-Jui Cheng, Song-Chang Lin, et al.
Annals of Surgical Oncology
|
June 25, 2011
Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy
Michael P Kim, Mark J Truty, Woonyoung Choi, et al.
The American Journal of Pathology
|
March 2, 2006
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
Jose G Trevino, Justin M Summy, Donald P Lesslie, et al.
Plos One
|
March 4, 2014
Cadherin-11 in renal cell carcinoma bone metastasis
Robert L Satcher, Tianhong Pan, Chien-Jui Cheng, et al.
Cancer Research
|
April 23, 2009
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress
Scott Kopetz, Donald P Lesslie, Nikolas A Dallas, et al.
Cancer Research
|
July 4, 2003
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways
Wenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes
Justin M Summy, Jose G Trevino, Donald P Lesslie, et al.
Page
of 12